These findings are supported by previous clinical studies demonstrating that both PDGFR-β and PDGF-D are up-regulated in primary prostate cancers and bone metastases, whereas PDGF-B is not frequently detected in clinical samples27. This evidence concerns the gene PDGFD and prostate carcinoma.